How Endogenous Tagging is Reshaping Protein Analysis

Understanding how proteins behave inside living cells is essential for modern drug discovery. Yet many widely used approaches, particularly plasmid overexpression systems and primary antibody–dependent assays, can alter or obscure the biology researchers aim to understand. Overexpression may push proteins above physiologically relevant levels, causing incorrect localization or artificial interactions. Antibody-driven detection strategies vary in performance, making it difficult to compare results across assays or sample types.

Endogenous tagging offers a way around these limitations. By inserting a reporter tag directly into the native genomic locus, researchers can monitor proteins under their natural regulatory control. This approach supports quantitative tracking of proteins in contexts where traditional methods struggle, enabling researchers to take advantage of sensitive reporter-based detection tools while preserving normal cellular expression patterns.

HiBiT-tagged CRISPR knock-in tools make this strategy practical for drug discovery applications. The HiBiT tag is only 11 amino acids long, minimizing disruption to protein folding or function. When complemented with its binding partner, LgBiT, the two components reconstitute a NanoLuc® luciferase, producing a bright, quantitative signal that tracks with protein abundance. The combination of a compact tag and sensitive detection enables researchers to measure endogenous expression levels that would otherwise be difficult to monitor.

Endogenous Tagging vs. Overexpression Systems

Plasmid-based expression is convenient but comes with a handful of tradeoffs. Non-native expression levels can alter subcellular localization, shift interaction partners, or introduce aggregation. These artifacts become particularly problematic when studying receptors, transcription factors, or targets involved in multi-protein complexes.

CRISPR-based knock-in tagging avoids these issues by inserting the reporter coding sequence directly into the genome. The tagged protein remains under natural transcriptional and post-transcriptional control, enabling more physiologically meaningful measurements. For researchers working with low-abundance proteins, tightly regulated targets, or systems prone to feedback and compensation, endogenous tagging provides a more faithful readout of biological activity.

The HiBiT system pairs knock-in precision with flexible detection options. Complementation with LgBiT enables quantitative, bioluminescent readouts in plate-based assays, live-cell workflows, and kinetic studies. The same tag can also be detected with an Anti-HiBiT monoclonal antibody, supporting compatibility with immunocytochemistry, flow cytometry, and immunoaffinity enrichment. This multi-modal detection is a key advantage over traditional epitope tags or fluorescent proteins, which often perform well in one application but not another.

Endogenous Tagging vs. Primary Antibody Detection

Primary antibody–dependent methods are foundational in biology, yet the reproducibility and specificity of antibodies can vary widely. Batch differences, cross-reactivity, and limited availability of high-quality antibodies for certain targets can all compromise assay performance.

With HiBiT tagging, detection does not rely on target-specific primary antibodies. Luminescent detection is mediated by the complementation event between HiBiT and LgBiT, producing a highly sensitive signal proportional to protein quantity. This eliminates concerns about antibody specificity, reduces assay complexity, and improves data consistency across experiments and sample types. When antibody-based workflows are needed, Anti-HiBiT antibody reagents provide a well-validated, high-affinity reagent that behaves consistently across formats.

Building a Complete Picture of Protein Dynamics

A major advantage of endogenous tagging is the ability to combine multiple assay modalities using the same reporter. HiBiT CRISPR knock-in cell models support:

• Quantitative measurement of protein abundance across treatments or timepoints, with scalability to high-throughput screening workflows
• Subcellular localization studies with immunocytochemistry or live-cell luminescence imaging
• Protein interaction mapping through IP-MS using Anti-HiBiT affinity reagents
• Analysis of post-translational modifications
• Real-time degradation kinetics, essential for characterizing targeted protein degraders and induced-proximity therapies

This breadth enables researchers to assemble a more complete understanding of a protein’s biology from a single engineered model.

A recent study using an endogenous HiBiT-tagged Epidermal Growth Factor Receptor (EGFR) demonstrates these capabilities. After CRISPR-mediated insertion of the HiBiT tag, researchers monitored ligand-induced internalization in real time using bioluminescent readouts. Complementary IP-MS experiments profiled EGFR interaction partners and phosphorylation states, illustrating how one knock-in cell line can support both dynamic and structural analyses. Similar strategies can be applied to targets involved in receptor signaling, protein quality control, or intracellular trafficking.

Although CRISPR editing once posed a barrier for many labs, endogenous tagging with HiBiT has become accessible through multiple adoption paths:

1. Ready-to-use HiBiT knock-in cell lines for immediate assay development and target validation
2. Custom tagging services and kits for engineering HiBiT into specific genes or disease-relevant cell models
3. Build-your-own workflows, where researchers design their own CRISPR reagents and obtain rights to synthesize the HiBiT tag for endogenous integration

These options enable teams to select the level of support that aligns with their timelines, expertise, and throughput needs.

Conclusion

Endogenous tagging provides a powerful alternative to overexpression or antibody-dependent detection, enabling researchers to monitor proteins as they function within their native regulatory environment. HiBiT-tagged CRISPR knock-in tools bring together genome editing precision, exceptional detection sensitivity and compatibility across assay formats, enabling researchers to generate reliable, high-confidence data on protein dynamics. As drug discovery increasingly focuses on mechanistic understanding—whether for degraders, molecular glues, or signaling targets—these capabilities provide a strong foundation for translational research.